XML 24 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash Flows From Operating Activities:      
Consolidated Net Income $ 14,091 $ 4,848 $ 5,111
Adjustments to Reconcile Net Income to Net Cash Provided by (Used in) Operating Activities:      
Provision for Loan Losses 2,390 4,237 1,220
Depreciation and Amortization 1,172 1,181 1,299
Net Accretion of Purchase Accounting Valuations (719) (4,529) (1,818)
Noncash Compensation (Income) Expense 1,010 (59) 456
Net Amortization of Securities 2,038 1,750 1,929
Gain on Sales of Securities (7) (31) (232)
Noncash (Income) Loss on Other Equity Securities (334) (243) 14
Gain on Sale of Premises and Equipment (24)
(Gain) Loss on Sale of Other Real Estate Owned, Net of Writedowns (14) 276 (72)
Increase in Cash Value of Life Insurance (681) (633) (788)
Provision (Credit) for Deferred Income Taxes (402) 3,126 953
Changes in Assets and Liabilities:      
Increase in Accrued Interest Receivable (970) (726) (561)
(Increase) Decrease in Other Assets 1,275 (675) 659
Increase (Decrease) in Accrued Interest Payable 184 (30) 354
Increase (Decrease) in Other Liabilities 243 (524) (350)
Net Cash Provided by Operating Activities 19,276 7,968 8,150
Cash Flows From Investing Activities:      
Purchases of Securities Available for Sale (16,106) (8,581) (45,935)
Proceeds from Maturities / Sales of Securities Available for Sale 11,417 7,881 30,589
Proceeds from Paydowns of Securities Available for Sale 33,670 19,625 23,828
Net Cash Paid in Merger (9,148)
Purchases of Other Equity Securities (1,175) (2,453) (866)
Redemption of Other Equity Securities 3,176 189 82
Life Insurance Proceeds 560
Net Increase in Loans (168,371) (164,419) (38,326)
Proceeds from Sale of Premises and Equipment 68
Purchases of Premises and Equipment (919) (505) (1,390)
Proceeds from Sales of Other Real Estate 654 1,084 1,659
Improvements to Other Real Estate (102)
Consideration Settlement to Former AGFC Shareholders (3,448)
Net Increase in Federal Funds Sold (23,516) (6,264) (60)
Net Cash Used in Investing Activities (170,318) (153,443) (33,341)
Cash Flows From Financing Activities:      
Net Increase in Deposits 124,471 122,738 28,559
Net Increase (Decrease) in Securities Sold Under Agreements to Repurchase (5,757) (781) 285
Net Advances (Repayments) on Federal Home Loan Bank Borrowings (25,000) 28,606 (1,349)
Net Decrease in Short Term Borrowings (862) (2,138)
Net Proceeds (Repayments) from Long Term Borrowings (2,700) (300) 3,000
Proceeds from Issuance of Subordinated Debt 25,000
Proceeds from Issuance of Common Stock 27,652 62,455
Repurchase of Common Stock (33) (863)
Proceeds from Exercise of Stock Warrants 15
Payment of Dividends on Common Stock (3,281) (1,792) (1,056)
Net Cash Provided by Financing Activities 139,523 210,893 26,453
Net Increase (Decrease) in Cash and Cash Equivalents (11,519) 65,418 1,262
Cash and Cash Equivalents at Beginning of Period 107,591 42,173 40,911
Cash and Cash Equivalents at End of Period 96,072 107,591 42,173
Supplemental Disclosures for Cash Flow Information:      
Interest on Deposits 11,384 6,351 4,779
Interest on Borrowings 2,098 908 693
Income Tax Payments 3,342 1,800 1,016
Supplemental Schedule for Noncash Investing and Financing Activities:      
Change in the Unrealized Gain (Loss) on Securities Available for Sale (2,310) 1,450 (2,336)
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale 485 (493) 795
Transfer of Loans to Other Real Estate 395 566 648
Transfer of Other Real Estate to Premises and Equipment $ 1,373 $ 175